Literature DB >> 24552151

Post-transcriptional control of cytokine gene expression in health and disease.

Khalid S A Khabar1.   

Abstract

Post-transcriptional control of cytokine gene expression is essential for rapid and transient response to stimuli and external stress. In health, post-transcriptional control is exerted by a number of trans-acting RNA-binding proteins and cis-acting sequence elements. These elements exist largely in the 3' untranslated region and comprise microRNA targets and notably AU-rich elements, and exert regulated mRNA decay and translation repression. Defects in this control can lead to increased and sustained production of pro-inflammatory mediators contributing to several chronic inflammatory disease and cancer states. This introduction to the Journal's special issue on the topic summarizes, in a non-comprehensive list, the types of RNA-binding protein and their target cytokines, and potential contributions to disease, and presents the highlights of the individual reviews.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24552151      PMCID: PMC3976584          DOI: 10.1089/jir.2013.0151

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  46 in total

Review 1.  Cell type- and stimulus-specific mechanisms for post-transcriptional control of neutrophil chemokine gene expression.

Authors:  Thomas Hamilton; Xiaoxia Li; Michael Novotny; Paul G Pavicic; Shyamasree Datta; Chenyang Zhao; Justin Hartupee; Dongxu Sun
Journal:  J Leukoc Biol       Date:  2011-12-13       Impact factor: 4.962

2.  Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites.

Authors:  Rickard Sandberg; Joel R Neilson; Arup Sarma; Phillip A Sharp; Christopher B Burge
Journal:  Science       Date:  2008-06-20       Impact factor: 47.728

3.  MicroRNA-155 regulates inflammatory cytokine production in tumor-associated macrophages via targeting C/EBPbeta.

Authors:  Min He; Zhenqun Xu; Tong Ding; Dong-Ming Kuang; Limin Zheng
Journal:  Cell Mol Immunol       Date:  2009-10       Impact factor: 11.530

4.  Activation of p38 MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destruction.

Authors:  Jochen Zwerina; Silvia Hayer; Kurt Redlich; Klaus Bobacz; Giorgos Kollias; Josef S Smolen; Georg Schett
Journal:  Arthritis Rheum       Date:  2006-02

Review 5.  Next stage of RA treatment: is TNF inhibitor-free remission a possible treatment goal?

Authors:  Yoshiya Tanaka
Journal:  Ann Rheum Dis       Date:  2012-12-19       Impact factor: 19.103

6.  Left-sided cardiac valvulitis in tristetraprolin-deficient mice: the role of tumor necrosis factor alpha.

Authors:  Sanjukta Ghosh; Mark J Hoenerhoff; Natasha Clayton; Page Myers; Deborah J Stumpo; Robert R Maronpot; Perry J Blackshear
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

7.  Tristetraprolin (TTP) gene polymorphisms in patients with rheumatoid arthritis and healthy individuals.

Authors:  Takeshi Suzuki; Akito Tsutsumi; Hiroyuki Suzuki; Eiji Suzuki; Makoto Sugihara; Yoshifumi Muraki; Taichi Hayashi; Yusuke Chino; Daisuke Goto; Isao Matsumoto; Satoshi Ito; Keiji Miyazawa; Takayuki Sumida
Journal:  Mod Rheumatol       Date:  2008-06-07       Impact factor: 3.023

8.  The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis.

Authors:  Lisa E Young; Sandhya Sanduja; Kristi Bemis-Standoli; Edsel A Pena; Robert L Price; Dan A Dixon
Journal:  Gastroenterology       Date:  2009-01-15       Impact factor: 22.682

9.  miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis.

Authors:  Christoph A Gebeshuber; Kurt Zatloukal; Javier Martinez
Journal:  EMBO Rep       Date:  2009-02-27       Impact factor: 8.807

10.  MicroRNA-146 inhibits pro-inflammatory cytokine secretion through IL-1 receptor-associated kinase 1 in human gingival fibroblasts.

Authors:  Yu-Feng Xie; Rong Shu; Shao-Yun Jiang; Da-Li Liu; Jing Ni; Xiu-Li Zhang
Journal:  J Inflamm (Lond)       Date:  2013-05-16       Impact factor: 4.981

View more
  3 in total

1.  Importance of the Conserved Carboxyl-Terminal CNOT1 Binding Domain to Tristetraprolin Activity In Vivo.

Authors:  Wi S Lai; Deborah J Stumpo; Melissa L Wells; Artiom Gruzdev; Stephanie N Hicks; Cindo O Nicholson; Zhengfeng Yang; Roberta Faccio; Michael W Webster; Lori A Passmore; Perry J Blackshear
Journal:  Mol Cell Biol       Date:  2019-06-13       Impact factor: 4.272

Review 2.  Post-transcriptional regulation of cytokine and growth factor signaling in cancer.

Authors:  Irina Vlasova-St Louis; Paul R Bohjanen
Journal:  Cytokine Growth Factor Rev       Date:  2016-12-02       Impact factor: 7.638

3.  Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+FoxP3+ regulatory T cells activation.

Authors:  Oriana Lo Re; Tommaso Mazza; Sebastiano Giallongo; Paola Sanna; Francesca Rappa; Tu Vinh Luong; Giovanni Li Volti; Adela Drovakova; Tania Roskams; Matthias Van Haele; Emmanuel Tsochatzis; Manlio Vinciguerra
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.